International Stem Cell Co. (OTCMKTS:ISCO) Short Interest Down 91.4% in December

International Stem Cell Co. (OTCMKTS:ISCO) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 300 shares, a drop of 91.4% from the November 30th total of 3,500 shares. Based on an average daily trading volume, of 6,000 shares, the short-interest ratio is currently 0.1 days.

International Stem Cell Stock Down 7.7 %

Shares of ISCO traded down $0.01 during mid-day trading on Thursday, hitting $0.10. The company had a trading volume of 2,037 shares, compared to its average volume of 4,406. International Stem Cell has a 1-year low of $0.05 and a 1-year high of $0.20. The business’s 50-day simple moving average is $0.09 and its 200-day simple moving average is $0.08. The stock has a market cap of $839,200.00, a PE ratio of -1.31 and a beta of 0.17.

International Stem Cell Company Profile

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.